HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.

Abstract
Staphylococcus lugdunensis has gained recognition as an atypically virulent pathogen with a unique microbiological and clinical profile. S. lugdunensis is coagulase negative due to the lack of production of secreted coagulase, but a membrane-bound form of the enzyme present in some isolates can result in misidentification of the organism as Staphylococcus aureus in the clinical microbiology laboratory. S. lugdunensis is a skin commensal and an infrequent pathogen compared to S. aureus and S. epidermidis, but clinically, infections caused by this organism resemble those caused by S. aureus rather than those caused by other coagulase-negative staphylococci. S. lugdunensis can cause acute and highly destructive cases of native valve endocarditis that often require surgical treatment in addition to antimicrobial therapy. Other types of S. lugdunensis infections include abscess and wound infection, urinary tract infection, and infection of intravascular catheters and other implanted medical devices. S. lugdunensis is generally susceptible to antimicrobial agents and shares CLSI antimicrobial susceptibility breakpoints with S. aureus. Virulence factors contributing to this organism's heightened pathogenicity remain largely unknown. Those characterized to date suggest that the organism has the ability to bind to and interact with host cells and to form biofilms on host tissues or prosthetic surfaces.
AuthorsKristi L Frank, José Luis Del Pozo, Robin Patel
JournalClinical microbiology reviews (Clin Microbiol Rev) Vol. 21 Issue 1 Pg. 111-33 (Jan 2008) ISSN: 1098-6618 [Electronic] United States
PMID18202439 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Anti-Bacterial Agents
  • Coagulase
Topics
  • Abscess (microbiology)
  • Acute Disease
  • Anti-Bacterial Agents (therapeutic use)
  • Biofilms (drug effects, growth & development)
  • Catheters, Indwelling (adverse effects)
  • Coagulase (analysis, metabolism)
  • Diagnosis, Differential
  • Endocarditis, Bacterial (microbiology, therapy)
  • Heart Valve Diseases (microbiology)
  • Heart Valve Prosthesis (adverse effects)
  • Humans
  • Microbial Sensitivity Tests
  • Prosthesis-Related Infections (microbiology)
  • Soft Tissue Infections (microbiology)
  • Staphylococcal Infections (diagnosis, etiology, microbiology)
  • Staphylococcus (drug effects, isolation & purification, pathogenicity, physiology)
  • Urinary Tract Infections (microbiology)
  • Virulence
  • Wound Infection (microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: